| Anne Tasaki, OD | |
|
200 Minor Hl, Berkeley, CA 94720-0001 | |
| (510) 642-2020 | |
| Not Available |
| Full Name | Anne Tasaki |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 11 Years |
| Location | 200 Minor Hl, Berkeley, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043640741 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 14817 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California At Berkeley | 8628083110 | 31 |
News Archive
Stillbirth is a tragedy that occurs in one of every 160 births in the United States. Compounding the sadness for many families, the standard medical test used to examine fetal chromosomes often can't pin down what caused their baby to die in utero. In most cases, the cause of the stillbirth is not immediately known.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Physician burnout continues to be a pervasive issue, with more than 50 percent of doctors reporting problems such as dissatisfaction, high rates of depression, and increased suicide risk.
Severely obese women are at an increased risk for producing eggs that have multiple spindles and disorganized chromosomes, possibly explaining the reduced fertility in this population, report researchers.
Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.
› Verified 5 days ago
| Provider Name | Permanente Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Stillbirth is a tragedy that occurs in one of every 160 births in the United States. Compounding the sadness for many families, the standard medical test used to examine fetal chromosomes often can't pin down what caused their baby to die in utero. In most cases, the cause of the stillbirth is not immediately known.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Physician burnout continues to be a pervasive issue, with more than 50 percent of doctors reporting problems such as dissatisfaction, high rates of depression, and increased suicide risk.
Severely obese women are at an increased risk for producing eggs that have multiple spindles and disorganized chromosomes, possibly explaining the reduced fertility in this population, report researchers.
Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.
› Verified 5 days ago
| Provider Name | Regents Of The University Of California At Berkeley |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306908058 PECOS PAC ID: 8628083110 Enrollment ID: O20060221000349 |
News Archive
Stillbirth is a tragedy that occurs in one of every 160 births in the United States. Compounding the sadness for many families, the standard medical test used to examine fetal chromosomes often can't pin down what caused their baby to die in utero. In most cases, the cause of the stillbirth is not immediately known.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Physician burnout continues to be a pervasive issue, with more than 50 percent of doctors reporting problems such as dissatisfaction, high rates of depression, and increased suicide risk.
Severely obese women are at an increased risk for producing eggs that have multiple spindles and disorganized chromosomes, possibly explaining the reduced fertility in this population, report researchers.
Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne Tasaki, OD 200 Minor Hl, Berkeley, CA 94720-0001 Ph: (510) 642-2020 | Anne Tasaki, OD 200 Minor Hl, Berkeley, CA 94720-0001 Ph: (510) 642-2020 |
News Archive
Stillbirth is a tragedy that occurs in one of every 160 births in the United States. Compounding the sadness for many families, the standard medical test used to examine fetal chromosomes often can't pin down what caused their baby to die in utero. In most cases, the cause of the stillbirth is not immediately known.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Physician burnout continues to be a pervasive issue, with more than 50 percent of doctors reporting problems such as dissatisfaction, high rates of depression, and increased suicide risk.
Severely obese women are at an increased risk for producing eggs that have multiple spindles and disorganized chromosomes, possibly explaining the reduced fertility in this population, report researchers.
Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.
› Verified 5 days ago
Dr. Carl H. Jacobsen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Minor Hall, Uc Berkeley, Berkeley, CA 94720 Phone: 510-643-9826 Fax: 510-642-4025 | |
Nancy Nguyen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: University Of California School Of Optometry, 230 Minor Hall, Berkeley, CA 94720 Phone: 510-642-0945 | |
Annie Chang, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1931 Dwight Way, Apt 20, Berkeley, CA 94704 Phone: 310-619-1266 | |
Dr. John Corzine, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Minor Hall, University Of California, Berkeley, CA 94720 Phone: 510-643-2793 Fax: 510-643-5109 | |
Dr. Ghazal Naseri, OD Optometrist Medicare: Medicare Enrolled Practice Location: 230 Minor Hall, Berkeley, CA 94720 Phone: 510-642-2020 | |
Daphne Chan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Minor Hl, University Of California, Berkeley, Berkeley, CA 94720 Phone: 510-642-0945 |